journal article·2024-05Open access

Bacteria Synergized with PD‐1 Blockade Enhance Positive Feedback Loop of Cancer Cells‐M1 Macrophages‐T Cells in Glioma

Qi Chen, Yuyi Zheng, Xiaojie Chen, Yuan Xing, Jiajie Zhang, Xinyi Yan, Qi Zhang, Di Wu, Zhong Chen

Advanced Science· Volume 11· Issue 20

Abstract

Abstract Cancer immunotherapy is an attractive strategy because it stimulates immune cells to target malignant cells by regulating the intrinsic activity of the immune system. However, due to lacking many immunologic markers, it remains difficult to treat glioma, a representative “cold” tumor. Herein, to wake the “hot” tumor immunity of glioma, Porphyromonas gingivalis (Pg) is customized with a coating to create an immunogenic tumor microenvironment and further prove the effect in combination with the immune checkpoint agent anti‐PD‐1, exhibiting elevated therapeutic efficacy. This is accomplished not by enhancing the delivery of PD‐1 blockade to enhance the effect of immunotherapy, but by introducing bacterial photothermal therapy to promote greater involvement of M1 cells in the immune response. After reaching glioma, the bacteria further target glioma cells and M2 phenotype macrophages selectively, enabling precise photothermal conversion for lysing tumor cells and M2 phenotype macrophages, which thereby enhances the positive feedback loop of cancer cells‐M1 macrophages‐T cells. Collectively, the bacteria synergized with PD‐1 blockade strategy may be the key to overcoming the immunosuppressive glioma microenvironment and improving the outcome of immunotherapy toward glioma.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Interdisciplinary Institute for Medical Engineering Fuzhou University Fuzhou Fujian 350108 China

Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province School of Pharmaceutical Sciences Zhejiang Chinese Medical University Hangzhou Zhejiang 310053 China

Funding

National Natural Science Foundation of China · National Basic Research Program of China · Zhejiang Chinese Medical University

References (46)

Show source-provided references
1. 10.3322/caac.2176310.3322/caac.21763 ↗
2. 10.1021/acsami.9b0022710.1021/acsami.9b00227 ↗
3. 10.2174/1570159X1866620062620400510.2174/1570159X18666200626204005 ↗
4. 10.1016/j.addr.2018.10.01310.1016/j.addr.2018.10.013 ↗
5. 10.1126/science.abn757010.1126/science.abn7570 ↗
6. 10.1056/NEJMra160898610.1056/NEJMra1608986 ↗
7. 10.1038/nature1067310.1038/nature10673 ↗
8. 10.1038/bcj.2015.710.1038/bcj.2015.7 ↗
9. 10.3389/fimmu.2023.116824410.3389/fimmu.2023.1168244 ↗
10. 10.1016/j.jconrel.2020.01.00510.1016/j.jconrel.2020.01.005 ↗
11. 10.1038/s41467-019-11719-310.1038/s41467-019-11719-3 ↗
12. 10.1038/s41467-022-34262-010.1038/s41467-022-34262-0 ↗
13. 10.1371/journal.pbio.100253310.1371/journal.pbio.1002533 ↗
14. 10.1038/s41467-019-11390-810.1038/s41467-019-11390-8 ↗
15. 10.1038/s41467-023-37225-110.1038/s41467-023-37225-1 ↗
16. 10.1038/s41568-018-0070-z10.1038/s41568-018-0070-z ↗
17. 10.1126/sciadv.aau333310.1126/sciadv.aau3333 ↗
18. 10.1016/j.nantod.2021.10131110.1016/j.nantod.2021.101311 ↗
19. 10.1016/j.nantod.2022.10153710.1016/j.nantod.2022.101537 ↗
20. 10.1002/adma.20180827810.1002/adma.201808278 ↗
21. 10.1038/s41467-019-13727-910.1038/s41467-019-13727-9 ↗
22. 10.3233/ADR-20025010.3233/ADR-200250 ↗
23. 10.1021/jacs.3c1120810.1021/jacs.3c11208 ↗
24. 10.1186/s12964-023-01142-z10.1186/s12964-023-01142-z ↗
25. 10.1021/acsomega.0c0584810.1021/acsomega.0c05848 ↗
26. 10.1021/acsnano.7b0696910.1021/acsnano.7b06969 ↗
27. 10.3324/haematol.2010.02387910.3324/haematol.2010.023879 ↗
28. 10.1016/j.apsb.2021.10.01910.1016/j.apsb.2021.10.019 ↗
29. 10.1038/s41467-021-24564-010.1038/s41467-021-24564-0 ↗
30. 10.1038/nri72710.1038/nri727 ↗
31. 10.1038/s41577-020-0306-510.1038/s41577-020-0306-5 ↗
32. 10.1038/s41586-022-05680-310.1038/s41586-022-05680-3 ↗
33. 10.1038/s41578-021-00394-w10.1038/s41578-021-00394-w ↗
34. 10.1515/CCLM.1999.00110.1515/CCLM.1999.001 ↗
35. 10.1016/j.it.2004.09.01510.1016/j.it.2004.09.015 ↗
36. 10.3389/fonc.2020.61035610.3389/fonc.2020.610356 ↗
37. 10.1016/j.jare.2021.08.00410.1016/j.jare.2021.08.004 ↗
38. 10.1016/j.jconrel.2016.04.01410.1016/j.jconrel.2016.04.014 ↗
39. 10.1038/s44222-023-00022-y10.1038/s44222-023-00022-y ↗
40. 10.1002/bab.223310.1002/bab.2233 ↗
41. 10.1038/362245a010.1038/362245a0 ↗
42. 10.1073/pnas.090274510610.1073/pnas.0902745106 ↗
43. 10.1073/pnas.100894210810.1073/pnas.1008942108 ↗
44. 10.1038/leu.2009.13910.1038/leu.2009.139 ↗
45. 10.1038/nm.389510.1038/nm.3895 ↗
46. 10.1038/s41467-021-26956-810.1038/s41467-021-26956-8 ↗